Antihypertensive drugs

A 419259 trihydrochloride.

A 419259 trihydrochloride.

Selective angiotensin-(1-7) antagonist.

A pan Akt inhibitor (Ki = 160 pmol/L for all three isoforms) that interferes with mitotic progression and bipolar spindle formation slows the progression of Akt-dependent tumors in vivo concomitantly increases Akt Thr308 and Ser473 phosphorylation

A pan Akt inhibitor (Ki = 160 pmol/L for all three isoforms) that interferes with mitotic progression and bipolar spindle formation slows the progression of Akt-dependent tumors in vivo concomitantly increases Akt Thr308 and Ser473 phosphorylation

Biochem/physiol Actions A-779 (D-Ala7-Ang-(1-7)) is a potent and selective antagonist of angiotensin (1-7), an endogenous peptide that acts through activation of a non-AT1, non-AT2 receptor, Mas, and opposes the activity of angiotensin. A-779 has

Biochem/physiol Actions A-779 (D-Ala7-Ang-(1-7)) is a potent and selective antagonist of angiotensin (1-7), an endogenous peptide that acts through activation of a non-AT1, non-AT2 receptor, Mas, and opposes the activity of angiotensin. A-779 has

Application &#945-Cyclodextrin can be used: In fabricating reversible supramolecular assemblies. As a modifier to enhance the solubility of oleic acid stabilized nanoparticles.

Application &#945-Cyclodextrin can be used: In fabricating reversible supramolecular assemblies. As a modifier to enhance the solubility of oleic acid stabilized nanoparticles.

Application &#945-Cyclodextrin can be used: In fabricating reversible supramolecular assemblies. As a modifier to enhance the solubility of oleic acid stabilized nanoparticles.

a-L-Galactose-1-phosphate dipotassium salt.

Application Intended for use in the Sigma &#945-Butyrate Esterase kit, procedure 181B Packaging 2.4g/L alpha-naphthyl butyrate in methanol solution with stabilizers